Prof.
Hadassah-Hebrew University Medical Center
Jerusalem, Yerushalayim, Israel
Dana Wolf is a physician-scientist and the Director of Clinical Virology at Hadassah Medical Center, Jerusalem, Israel. She is a Professor at the Hebrew University, Jerusalem, Israel. She received her MD degree from the Hebrew University, and completed Virology Fellowship and Sabbatical at the University of California San Diego and Stanford University. She is a member of several national and international advisory committees, including the Israeli Advisory Committee on Immunization Practices and Infectious Diseases, and the European Society for Virology Executive Board. Her research interests focus on the diagnosis, transmission, and pathogenesis of human viruses and on new antiviral strategies.
Focusing on human cytomegalovirus, she leads research projects focusing on ex vivo viral infection models - revealing modes of viral transmission and immune defense in native human tissues, and on new diagnostic and antiviral strategies. Over the years, she has translated her expertise in molecular virology to the development of advanced diagnostic approaches. Upon the onset of COVID-19, her lab has developed and pioneered a sample-pooling setup, enabling the high throughput screening of SARS-CoV-2, and leading to the widespread implementation of this technology. Building on this preexisting pooling pipeline, she has recently developed and implemented a new pooling setup for large-scale universal newborn screening of congenital CMV infection and demonstrated its high accuracy and feasibility.
Disclosure(s): GSK: Advisor/Consultant; Merck: Grant/Research Support; Moderna: Grant/Research Support; MSD: Advisor/Consultant; Takeda: Advisor/Consultant
Friday, October 18, 2024
2:33 PM – 2:45 PM US PT